Finally, we show that the efficacy of DHE in suppressing SE-dependent expression of MYC in vitro, and MYC-dependent AML maintenance in vivo, is similar to that of BET bromodomain inhibitor JQ1. The gene discussed is MYC; the disease is acute myeloid leukemia.